ECMO and impella increase stroke risk in acute myocardial infarction

Abstract There is limited data on the risk of stroke in patients with acute myocardial infarction (AMI) treated with temporary mechanical circulatory support devices. Retrospective data were extracted from the U.S. National Inpatient Sample between October 2015 and December 2020, involving hospitali...

Full description

Saved in:
Bibliographic Details
Main Authors: Jing Wu, Chenguang Li, Zheng Xu, Baoguo Wang, Mingyou Zhang
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-10555-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849763254480404480
author Jing Wu
Chenguang Li
Zheng Xu
Baoguo Wang
Mingyou Zhang
author_facet Jing Wu
Chenguang Li
Zheng Xu
Baoguo Wang
Mingyou Zhang
author_sort Jing Wu
collection DOAJ
description Abstract There is limited data on the risk of stroke in patients with acute myocardial infarction (AMI) treated with temporary mechanical circulatory support devices. Retrospective data were extracted from the U.S. National Inpatient Sample between October 2015 and December 2020, involving hospitalizations for AMI. The final cohort comprised: 4,370,069 hospitalizations with medical therapy only, 136,005 with intra-aortic balloon pump (IABP) only, 41,560 with Impella only, and 10,695 with extracorporeal membrane oxygenation (ECMO) utilized during hospitalization. The overall stroke rates for patients receiving medical therapy only, IABP only, Impella only, and ECMO were 3.39%, 3.56%, 4.54%, and 13.14%, respectively. Specifically, ischemic stroke rates were 2.93%, 3.17%, 3.96%, and 9.91%, and hemorrhagic stroke rates were 0.69%, 0.59%, 0.87%, and 4.77% for the respective groups. In stepwise forward Cox regression analysis, ECMO use was associated with the highest adjusted odds ratio (aOR) for overall stroke (aOR 3.04, 95% CI [2.66–3.48]), followed by Impella alone (aOR 1.79, 95% CI [1.61–2.00]) and atrial fibrillation (aOR 1.34, 95% CI [1.31–1.38]). However, IABP use showed no significant association with increased stroke risk in either univariate or multivariate analyses. While IABP use is not associated with an increased risk of ischemic or hemorrhagic stroke, ECMO and Impella use are linked to a higher stroke risk, particularly for ECMO-treated AMI.
format Article
id doaj-art-a36419c9e9364d00aadf8930504a693c
institution DOAJ
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-a36419c9e9364d00aadf8930504a693c2025-08-20T03:05:27ZengNature PortfolioScientific Reports2045-23222025-07-011511810.1038/s41598-025-10555-4ECMO and impella increase stroke risk in acute myocardial infarctionJing Wu0Chenguang Li1Zheng Xu2Baoguo Wang3Mingyou Zhang4Department of Translational Medicine, The First Hospital of Jilin UniversityDepartment of Cardiology, Zhongshan HospitalDepartment of Cardiovascular Diseases, The First Hospital of Jilin UniversityDepartment of Cardiovascular Diseases, The First Hospital of Jilin UniversityDepartment of Cardiovascular Diseases, The First Hospital of Jilin UniversityAbstract There is limited data on the risk of stroke in patients with acute myocardial infarction (AMI) treated with temporary mechanical circulatory support devices. Retrospective data were extracted from the U.S. National Inpatient Sample between October 2015 and December 2020, involving hospitalizations for AMI. The final cohort comprised: 4,370,069 hospitalizations with medical therapy only, 136,005 with intra-aortic balloon pump (IABP) only, 41,560 with Impella only, and 10,695 with extracorporeal membrane oxygenation (ECMO) utilized during hospitalization. The overall stroke rates for patients receiving medical therapy only, IABP only, Impella only, and ECMO were 3.39%, 3.56%, 4.54%, and 13.14%, respectively. Specifically, ischemic stroke rates were 2.93%, 3.17%, 3.96%, and 9.91%, and hemorrhagic stroke rates were 0.69%, 0.59%, 0.87%, and 4.77% for the respective groups. In stepwise forward Cox regression analysis, ECMO use was associated with the highest adjusted odds ratio (aOR) for overall stroke (aOR 3.04, 95% CI [2.66–3.48]), followed by Impella alone (aOR 1.79, 95% CI [1.61–2.00]) and atrial fibrillation (aOR 1.34, 95% CI [1.31–1.38]). However, IABP use showed no significant association with increased stroke risk in either univariate or multivariate analyses. While IABP use is not associated with an increased risk of ischemic or hemorrhagic stroke, ECMO and Impella use are linked to a higher stroke risk, particularly for ECMO-treated AMI.https://doi.org/10.1038/s41598-025-10555-4StrokeAcute myocardial infarctionTemporary mechanical circulatory supportImpellaIntra-aortic balloon counterpulsationExtracorporeal membrane oxygenation
spellingShingle Jing Wu
Chenguang Li
Zheng Xu
Baoguo Wang
Mingyou Zhang
ECMO and impella increase stroke risk in acute myocardial infarction
Scientific Reports
Stroke
Acute myocardial infarction
Temporary mechanical circulatory support
Impella
Intra-aortic balloon counterpulsation
Extracorporeal membrane oxygenation
title ECMO and impella increase stroke risk in acute myocardial infarction
title_full ECMO and impella increase stroke risk in acute myocardial infarction
title_fullStr ECMO and impella increase stroke risk in acute myocardial infarction
title_full_unstemmed ECMO and impella increase stroke risk in acute myocardial infarction
title_short ECMO and impella increase stroke risk in acute myocardial infarction
title_sort ecmo and impella increase stroke risk in acute myocardial infarction
topic Stroke
Acute myocardial infarction
Temporary mechanical circulatory support
Impella
Intra-aortic balloon counterpulsation
Extracorporeal membrane oxygenation
url https://doi.org/10.1038/s41598-025-10555-4
work_keys_str_mv AT jingwu ecmoandimpellaincreasestrokeriskinacutemyocardialinfarction
AT chenguangli ecmoandimpellaincreasestrokeriskinacutemyocardialinfarction
AT zhengxu ecmoandimpellaincreasestrokeriskinacutemyocardialinfarction
AT baoguowang ecmoandimpellaincreasestrokeriskinacutemyocardialinfarction
AT mingyouzhang ecmoandimpellaincreasestrokeriskinacutemyocardialinfarction